Outset Medical (OM) insider Leslie Trigg plans Rule 144 stock sale

Rhea-AI Filing Summary

Outset Medical insider plans additional stock sale under Rule 144. The filing indicates that Leslie Trigg intends to sell 2,120 shares of Outset Medical common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 10,696.59. The shares relate to equity compensation and are part of a broader pattern of recent sales.

The notice also reports prior sales over the past three months, including 916 shares on 11/17/2025, 1,795 shares on 01/07/2026, and 11,794 shares on 01/20/2026, for gross proceeds of 4,213.60, 7,664.65, and 60,385.28, respectively. The issuer had 18,153,090 shares of common stock outstanding, providing context for the scale of these transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	2120	10696.59	18153090	01/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/17/2026	Settlement of Vested Restricted Stock Units	Issuer			32552	01/17/2026	Equity compensation for services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Leslie Trigg 3052 Orchard Drive San Jose CA 95134	Common Stock	11/17/2025	916	4213.60
Leslie Trigg 3052 Orchard Drive San Jose CA 95134	Common	01/07/2026	1795	7664.65
Leslie Trigg 3052 Orchard Drive San Jose CA 95134	Common	01/20/2026	11794	60385.28

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Outset Medical (OM) Form 144 filed by Leslie Trigg disclose?

The Form 144 discloses that Leslie Trigg intends to sell 2,120 shares of Outset Medical common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 10,696.59, under Rule 144.

How many Outset Medical (OM) shares has Leslie Trigg sold recently?

Over the past three months, the filing reports sales of 916 shares on 11/17/2025, 1,795 shares on 01/07/2026, and 11,794 shares on 01/20/2026, for total disclosed gross proceeds of 4,213.60, 7,664.65, and 60,385.28, respectively.

How were the Outset Medical (OM) shares to be sold by Leslie Trigg acquired?

The Form 144 states that the common stock was acquired on 01/17/2026 through the settlement of vested restricted stock units from the issuer as equity compensation for services rendered, in the amount of 32,552 shares.

What is the reported number of Outset Medical (OM) shares outstanding in this filing?

The filing reports that Outset Medical had 18,153,090 shares of common stock outstanding, providing a baseline for understanding the size of the planned and recent insider sales.

Which broker and exchange are involved in the planned Outset Medical (OM) share sale?

The planned sale of 2,120 shares is to be executed through Morgan Stanley Smith Barney LLC, with trades on the NASDAQ exchange.

What assurance does the Form 144 for Outset Medical (OM) provide about undisclosed information?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.